63915 Association between Cutaneous Immune-Related Adverse Events and Survival in Advanced Stage III and Stage IV Melanoma Patients Treated with Combination Nivolumab and Relatlimab

Authors

Shaliz Aflatooni, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

9-2025

Volume

93

Issue

3

Published In/Presented At

https://doi.org/10.1016/j.jaad.2025.05.506

Disciplines

Medical Education | Medicine and Health Sciences

Department(s)

USF-LVHN SELECT Program, USF-LVHN SELECT Program Students

Document Type

Article